Denali Current Liabilities vs Total Assets Analysis

DNLI Stock  USD 20.52  0.25  1.20%   
Trend analysis of Denali Therapeutics balance sheet accounts such as Total Current Liabilities of 121.8 M or Total Stockholder Equity of 712.9 M provides information on Denali Therapeutics' total assets, liabilities, and equity, which is the actual value of Denali Therapeutics to its prevalent stockholders. By breaking down trends over time using Denali Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.

About Denali Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Denali Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Denali Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Denali Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Denali currently owns. An asset can also be divided into two categories, current and non-current.

Denali Therapeutics Balance Sheet Chart

Denali Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Denali Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
As of now, Denali Therapeutics' Non Current Assets Total are increasing as compared to previous years. The Denali Therapeutics' current Non Currrent Assets Other is estimated to increase to about 17.4 M, while Total Assets are projected to decrease to under 932.8 M.

Total Assets

Total assets refers to the total amount of Denali Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Denali Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Denali Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Denali Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Denali Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Denali Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.The current Selling General Administrative is estimated to decrease to about 54.3 M. The current Tax Provision is estimated to decrease to -6,300
 2021 2022 2023 2024 (projected)
Interest Income4.6M14.8M51.5M54.1M
Net Interest Income4.6M14.8M45.0M47.3M

Denali Therapeutics fundamental ratios Correlations

0.910.750.990.490.960.89-0.75-0.790.430.850.640.720.640.980.650.920.50.930.930.940.90.790.770.980.66
0.910.770.910.210.910.88-0.53-0.890.570.670.490.770.530.910.590.870.280.890.920.960.790.840.660.910.59
0.750.770.69-0.040.670.67-0.41-0.670.310.520.720.640.860.670.40.690.040.680.860.740.830.540.470.680.43
0.990.910.690.460.980.88-0.71-0.820.50.820.610.760.580.970.710.930.450.940.910.950.820.810.830.980.72
0.490.21-0.040.460.440.38-0.760.01-0.250.720.09-0.080.070.540.220.360.970.290.210.290.510.20.330.530.22
0.960.910.670.980.440.87-0.69-0.810.510.790.560.750.560.960.570.940.450.940.910.950.80.80.760.960.57
0.890.880.670.880.380.87-0.5-0.810.480.670.570.680.530.870.640.940.450.880.890.910.80.890.770.870.64
-0.75-0.53-0.41-0.71-0.76-0.69-0.50.260.03-0.97-0.42-0.18-0.37-0.75-0.37-0.49-0.73-0.55-0.47-0.51-0.74-0.33-0.51-0.74-0.38
-0.79-0.89-0.67-0.820.01-0.81-0.810.26-0.83-0.46-0.45-0.95-0.41-0.78-0.59-0.84-0.04-0.93-0.87-0.9-0.59-0.94-0.62-0.78-0.6
0.430.570.310.5-0.250.510.480.03-0.830.170.340.87-0.030.40.410.53-0.220.720.50.580.190.80.350.410.4
0.850.670.520.820.720.790.67-0.97-0.460.170.50.360.40.850.460.640.720.720.610.650.830.550.580.850.47
0.640.490.720.610.090.560.57-0.42-0.450.340.50.550.670.470.50.630.10.60.640.560.640.460.580.470.51
0.720.770.640.76-0.080.750.68-0.18-0.950.870.360.550.440.680.530.8-0.060.890.830.830.520.850.560.680.55
0.640.530.860.580.070.560.53-0.37-0.41-0.030.40.670.440.560.350.620.080.480.760.590.710.260.510.560.38
0.980.910.670.970.540.960.87-0.75-0.780.40.850.470.680.560.620.890.550.90.890.930.860.780.741.00.63
0.650.590.40.710.220.570.64-0.37-0.590.410.460.50.530.350.620.60.120.610.560.660.410.60.890.621.0
0.920.870.690.930.360.940.94-0.49-0.840.530.640.630.80.620.890.60.40.920.950.960.790.850.770.90.61
0.50.280.040.450.970.450.45-0.73-0.04-0.220.720.1-0.060.080.550.120.40.310.270.330.590.260.240.550.12
0.930.890.680.940.290.940.88-0.55-0.930.720.720.60.890.480.90.610.920.310.90.930.760.930.710.910.62
0.930.920.860.910.210.910.89-0.47-0.870.50.610.640.830.760.890.560.950.270.90.970.840.80.690.890.58
0.940.960.740.950.290.950.91-0.51-0.90.580.650.560.830.590.930.660.960.330.930.970.780.860.760.930.67
0.90.790.830.820.510.80.8-0.74-0.590.190.830.640.520.710.860.410.790.590.760.840.780.620.50.860.42
0.790.840.540.810.20.80.89-0.33-0.940.80.550.460.850.260.780.60.850.260.930.80.860.620.630.790.61
0.770.660.470.830.330.760.77-0.51-0.620.350.580.580.560.510.740.890.770.240.710.690.760.50.630.740.89
0.980.910.680.980.530.960.87-0.74-0.780.410.850.470.680.561.00.620.90.550.910.890.930.860.790.740.63
0.660.590.430.720.220.570.64-0.38-0.60.40.470.510.550.380.631.00.610.120.620.580.670.420.610.890.63
Click cells to compare fundamentals

Denali Therapeutics Account Relationship Matchups

Denali Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets553.2M1.6B1.4B1.5B1.2B932.8M
Other Current Liab20.4M42.5M47.7M63.8M61.2M31.3M
Total Current Liabilities45.3M71.7M378.2M363.9M78.0M121.8M
Total Stockholder Equity394.9M1.2B962.3M1.0B1.0B712.9M
Other Liab44.1M317.9M5.1M858K986.7K937.4K
Net Tangible Assets394.9M1.2B962.3M1.0B1.2B612.3M
Property Plant And Equipment Net80.7M73.5M69.6M74.5M71.6M52.4M
Net Debt(10.6M)(443.0M)(234.9M)(157.7M)(74.9M)(78.6M)
Retained Earnings(425.6M)(354.4M)(645.0M)(971.0M)(1.1B)(1.1B)
Accounts Payable2.6M1.1M4.8M2.8M9.5M10.0M
Cash79.4M507.1M293.5M218.0M127.1M194.5M
Non Current Assets Total123.2M108.6M506.9M87.9M89.8M154.9M
Non Currrent Assets Other2.7M2.5M11.9M11.9M16.5M17.4M
Other Assets2.7M2.5M11.9M13.4M1.00.95
Cash And Short Term Investments415.4M1.5B865.4M1.3B1.0B757.9M
Common Stock Shares Outstanding95.6M112.7M121.5M125.5M137.4M86.7M
Liabilities And Stockholders Equity553.2M1.6B1.4B1.5B1.2B932.8M
Non Current Liabilities Total113.0M382.1M63.6M53.9M45.0M42.7M
Capital Surpluse774.2M818.8M1.5B1.6B1.8B1.9B
Other Current Assets14.7M20.3M30.6M36.1M26.9M18.9M
Other Stockholder Equity818.8M1.5B1.6B2.0B2.1B1.1B
Total Liab158.3M453.7M441.9M417.8M123.0M220.0M
Property Plant And Equipment Gross80.7M73.5M69.6M74.5M117.6M123.5M
Total Current Assets430.0M1.5B897.2M1.4B1.1B778.0M
Accumulated Other Comprehensive Income350K(245K)(2.5M)(6.9M)643K675.2K
Common Stock1.3M1.5M1.5M1.7M1.7M1.6M
Property Plant Equipment80.7M40.8M69.6M74.5M85.7M44.6M
Short Term Investments335.9M962.6M571.9M1.1B907.4M633.8M
Long Term Investments61.3M147.9M39.9M32.7M425.4M0.0
Non Current Liabilities Other467K471K379K382.1M435.9K414.1K
Net Invested Capital394.9M1.2B962.3M1.0B1.0B879.0M
Net Working Capital384.7M1.4B519.0M1.0B986.2M811.7M
Current Deferred Revenue18.7M23.5M320.3M290.1M333.6M350.2M
Capital Stock1.3M1.5M1.5M1.7M1.7M1.7M
Short Term Debt3.7M4.7M5.5M7.3M7.3M6.3M

Pair Trading with Denali Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Denali Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Denali Stock

  0.62VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
  0.47TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Denali Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Denali Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Denali Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Denali Therapeutics to buy it.
The correlation of Denali Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Denali Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Denali Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Denali Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Denali Stock analysis

When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.06)
Revenue Per Share
2.406
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.09)
Return On Equity
(0.14)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.